Download PDF
Hamostaseologie 2020; 40(05): 631-641
DOI: 10.1055/a-1141-1175
Original Article

Health-Related Quality of Life, Treatment Satisfaction and Adherence Outcomes of Haemophilia Patients Living in a German Rural Region

Sylvia von Mackensen
1   Department for Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
,
Christian Schleicher
2   Institute of Clinical Haemostaseology and Transfusion Medicine, European Haemophilia Comprehensive Care Centre, Saarland University Hospital, Homburg, Saar, Germany
,
Sabine Heine
3   Department for Paediatric Oncology and Haematology, European Haemophilia Comprehensive Care Centre, Saarland University Hospital, Homburg, Saar, Germany
,
Norbert Graf
3   Department for Paediatric Oncology and Haematology, European Haemophilia Comprehensive Care Centre, Saarland University Hospital, Homburg, Saar, Germany
,
Hermann Eichler
2   Institute of Clinical Haemostaseology and Transfusion Medicine, European Haemophilia Comprehensive Care Centre, Saarland University Hospital, Homburg, Saar, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

In the context of the ‘Mobile Haemophilia Outpatient Care (MHOC)’ project we aimed to gather insights into the health-related quality of life (HRQoL), treatment satisfaction (TS) and adherence of persons with haemophilia (PWHs) who get treated at the Saarland University Hospital Haemophilia Treatment Centre (HTC). PWHs were visited at home at least twice (baseline, follow-up) by trained medical staff. Individual interviews were performed to measure patients' HRQoL and TS with validated questionnaires (Haem-A-QoL/Haemo-QoL and Hemo-SatA/Hemo-SatP). Socio-demographic and clinical data were collected. In total, 79 PWHs were enrolled; 56 adults with a mean age of 37.4 ± 16.4 years (17–78) and 23 children [mean age of 9.8 ± 4.2 years (3–16)]. In total, 62% were severely affected; 48.1% received prophylaxis. Patients reported good HRQoL (adults: 23.1 ± 17.1; kids: 24.3 ± 11.1). Patients (M = 11.2 ± 9.5) and parents (M = 14.3 ± 7.4) were very satisfied with their provided treatment. The majority of study participants were evaluated to have a good treatment adherence. After 1-year follow-up of the MHOC, a significant improvement in HRQoL was seen in adults (p < 0.033) and in proxy ratings of parents (p < 0.0001); TS remained high with no change by MHOC intervention. Patients reported good HRQoL and TS. Most of them were evaluated as having a good treatment adherence. After implementation of the MHOC, adult patients reported a better HRQoL. Such a mobile medical care service is considered beneficial for patients, especially with limited access to a HTC.

Keywords

haemophilia - haemophilia treatment centre - health-related quality of life - treatment satisfaction - adherence - adults - children

Authors' Contributions

Sylvia von Mackensen (S.v.M.) and Hermann Eichler (H.E.) were involved in the planning of the project, analysing the data and writing of the manuscript. Christian Schleicher (C.S.) was involved in the management of the study, patient recruitment, data generation by performing patient interviews, contributed to data analysis and gave relevant input during the review of the manuscript; Sabine Heine (S.H.) was involved in patient recruitment and reviewed the results and the manuscript; Norbert Graf (N.G.) was involved in management of the study and gave relevant input during the review of the manuscript.




Publication History

Received: 13 December 2019

Accepted: 18 March 2020

Article published online:
04 May 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med 1970; 283 (19) 1011-1015
    CrossrefPubMedGoogle Scholar
  • 2 Nilsson IM. Experience with prophylaxis in Sweden. Semin Hematol 1993; 30 (03) (Suppl. 02) 16-19
    PubMedGoogle Scholar
  • 3 Teitel JM, Barnard D, Israels S, Lillicrap D, Poon MC, Sek J. Home management of haemophilia. Haemophilia 2004; 10 (02) 118-133
    CrossrefPubMedGoogle Scholar
  • 4 Srivastava A, Brewer AK, Mauser-Bunschoten EP. et al; Treatment Guidelines Working Group on Behalf of the World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (01) e1-e47
    CrossrefPubMedGoogle Scholar
  • 5 Bensadok M, Almomen A, Alzoebie A. et al. Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries. Blood Coagul Fibrinolysis 2017; 28 (02) 145-151
    CrossrefPubMedGoogle Scholar
  • 6 Manco-Johnson MJ, Abshire TC, Shapiro AD. et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357 (06) 535-544
    CrossrefPubMedGoogle Scholar
  • 7 Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7 (04) 392-396
    CrossrefPubMedGoogle Scholar
  • 8 Llewellyn CD, Miners AH, Lee CA, Harrington C, Weinman J. The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychol Health 2003; 18 (02) 185-200
    CrossrefPubMedGoogle Scholar
  • 9 du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007; 13 (05) 493-501
    CrossrefPubMedGoogle Scholar
  • 10 Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia 2012; 18 (05) 760-765
    CrossrefPubMedGoogle Scholar
  • 11 von Mackensen S, Gringeri A. Quality of life in haemophilia. In: Preedy VR, Watson RR. eds. Handbook of Disease Burdens and Quality of Life Measures. Heidelberg: Springer; 2010: 1895-1920
    CrossrefGoogle Scholar
  • 12 Bonanad S, Schulz M, Gordo A. et al. HaemoPREF: further evaluation of patient perception and preference for treatment in a real world setting. Haemophilia 2017; 23 (06) 884-893
    CrossrefPubMedGoogle Scholar
  • 13 Colvin BT, Astermark J, Fischer K. et al; Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14 (02) 361-374
    CrossrefPubMedGoogle Scholar
  • 14 Berntorp E, Boulyjenkov V, Brettler D. et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73 (05) 691-701
    PubMedGoogle Scholar
  • 15 Kasper CK, Mannucci PM, Bulyzhenkov V. et al. Haemophilia in the 1990s: report of a joint meeting of the World Health Organization and World Federation of Hemophilia. Vox Sang 1991; 61 (03) 221-224
    CrossrefPubMedGoogle Scholar
  • 16 Novais T, Duclos A, Varin R, Lopez I, Chamouard V. Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers. Int J Clin Pharm 2016; 38 (01) 61-69
    CrossrefPubMedGoogle Scholar
  • 17 Eichler H, Pedroni MA, Halimeh S. et al. Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren [in German]. Hamostaseologie 2019; 39 (04) 311-321
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Pritchard AM, Reimer M, Simonson K, Oberle K. Partnerships in specialty care: exploring rural haemophilia provider resource needs. Aust J Rural Health 2006; 14 (05) 184-189
    CrossrefPubMedGoogle Scholar
  • 19 Eichler H, Schleicher C, Heine S, Graf N, von Mackensen S. Feasibility and results of a mobile haemophilia outpatient care pilot project. Hamostaseologie 2018; 38 (03) 129-140
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist 2009; 74: 1-39
    PubMedGoogle Scholar
  • 21 von Mackensen S, Scalone L, Ravera S, Mantovani LG, Gringeri A. Assessment of health-related quality of life in patients with haemophilia with the newly developed haemophilia-specific instrument HAEM-A-QOL. Value Health 2005; 8: A127 [Abstract]
    CrossrefPubMedGoogle Scholar
  • 22 von Mackensen S, Bullinger M. ;Haemo-QoL Group. Development and testing of an instrument to assess the quality of life of children with haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10 (Suppl. 01) 17-25
    CrossrefPubMedGoogle Scholar
  • 23 von Mackensen S, Gringeri A, Mantovani L. Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo-SatA). Haemophilia 2004; 10 (Suppl. 03) 126
    CrossrefPubMedGoogle Scholar
  • 24 Holstein K, von Mackensen S, Bokemeyer C, Langer F. The impact of social factors on outcomes in patients with bleeding disorders. Haemophilia 2016; 22 (01) 46-53
    CrossrefPubMedGoogle Scholar
  • 25 Cohen J. Statistical Power Analysis JC for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988
    Google Scholar
  • 26 Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D. et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001;149: 807–818
    PubMed
  • 27 Care4You - Das Unterstützungsprogramm für Menschen mit Hämophilie. Accessed December 13, 2019 at: https://sobi-deutschland.de/sites/sobi-deutschland.de/files/Brosch_Care4you_Pat.pdf
    PubMedGoogle Scholar
  • 28 Shire Patientenservice – Therapien in gewohnter Umgebung. Accessed January 10, 2020 at: https://shire-patientenservice.de/
    PubMedGoogle Scholar
  • 29 Rossnagel E, Oliffe JL, Jackson Y, Bartholomew C. Haemophilia home care: a qualitative evaluation study of the Be Involved infusion program. Haemophilia 2019; 25 (05) 807-813
    CrossrefPubMedGoogle Scholar
  • 30 Mondorf W, Eichler H, Fischer R. et al. Smart Medication™, an electronic diary for surveillance of haemophilia home care and optimization of resource distribution. Hamostaseologie 2019; 39 (04) 339-346
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Mondorf W, Siegmund B, Mahnel R. et al. Haemoassist--a hand-held electronic patient diary for haemophilia home care. Haemophilia 2009; 15 (02) 464-472
    CrossrefPubMedGoogle Scholar
  • 32 Banchev A, Goldmann G, Marquardt N. et al. Impact of telemedicine tools on record keeping and compliance in haemophilia care. Hamostaseologie 2019; 39 (04) 347-354
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Britten AF. A little freedom for the hemophiliac. N Engl J Med 1970; 283 (19) 1051-1052
    CrossrefPubMedGoogle Scholar
  • 34 Nugent D, Kalnins W, Querol F. et al. Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia 2015; 21 (01) e26-e38
    CrossrefPubMedGoogle Scholar
  • 35 Wong TE, Majumdar S, Adams E. et al; Healthy Weight Working Group. Overweight and obesity in hemophilia: a systematic review of the literature. Am J Prev Med 2011; 41 (06) (Suppl. 04) S369-S375
    CrossrefPubMedGoogle Scholar
  • 36 Haftenberger M, Mensink GB, Herzog B. et al. Changes in body weight and obesity status in German adults: results of seven population-based prospective studies. Eur J Clin Nutr 2016; 70 (03) 300-305
    CrossrefPubMedGoogle Scholar
  • 37 Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15 (04) 894-899
    CrossrefPubMedGoogle Scholar
  • 38 Santagostino E, Lentz SR, Busk AK, Regnault A, Iorio A. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa. Haemophilia 2014; 20 (04) 527-534
    CrossrefPubMedGoogle Scholar
  • 39 Wyrwich KW, Krishnan S, Poon JL. et al. Interpreting important health-related quality of life change using the Haem-A-QoL. Haemophilia 2015; 21 (05) 578-584
    CrossrefPubMedGoogle Scholar
  • 40 von Mackensen S, Shah J, Seifert W, Kenet G. Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP. Haemophilia 2019; 25 (01) 45-53
    CrossrefPubMedGoogle Scholar
  • 41 Ozelo MRA, Slothuus U, Hoxer CS. Satisfaction of young adults with haemophilia A previously treated with prophylaxis and switching to prophylactic treatment with recombinant factor VIII Turoctocog Alfa. Haemophilia 2015; 21 (02) 14-94
    CrossrefPubMedGoogle Scholar
  • 42 Megías-Vericat JE, Monte-Boquet E, Martín-Cerezuela M. et al. Pilot evaluation of home delivery programme in haemophilia. J Clin Pharm Ther 2018; 43 (06) 822-828
    CrossrefPubMedGoogle Scholar
  • 43 Kearney S, Raffini LJ, Pham TP. et al. Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII. Patient Prefer Adherence 2019; 13: 497-513
    CrossrefPubMedGoogle Scholar
  • 44 Schrijvers LH, Schuurmans MJ, Fischer K. Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals. Haemophilia 2016; 22 (04) 499-506
    CrossrefPubMedGoogle Scholar